COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND IDO1 INHIBITOR FOR THE TREATMENT OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20210002371A1
SERIAL NO

16955477

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises an anti-PD-L1 antibody and an IDO1 inhibitor. The therapeutic combination is particularly intended for use in treating a subject having a cancer that tests positive for PD-L1 or IDO1 expression.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK PATENT GMBHFRANKFURTER STRASSE 250 DARMSTADT 64293

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GIMMI, Claude Moehlin, CH 4 0
MOISAN, Jacques Acton, US 3 10
SHERER, Brian A Nashua, US 25 116

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation